Foresite’s 2nd SPAC deal counts Gilead as an investor in $276M bid for COVID-19 biotech Pardes

Foresite’s 2nd SPAC deal counts Gilead as an investor in $276M bid for COVID-19 biotech Pardes aalidrus Tue, 06/29/2021 - 10:19

Click to view original post